Michael J. Peluso

Infectious Disease

995 Potrero Ave
San Francisco, CA 94110

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 244 publications

HIV DNA and transcription before and after ART in natural controllers compared to noncontrollers.

HIV DNA and transcription before and after ART in natural controllers compared to noncontrollers.

Journal: Journal of virology

Published: August 24, 2026

Health-related quality of life trajectories during analytical treatment interruptions in HIV cure-related studies and the influence of depression, anxiety, and resilience.

Health-related quality of life trajectories during analytical treatment interruptions in HIV cure-related studies and the influence of depression, anxiety, and resilience.

Journal: HIV research & clinical practice

Published: August 06, 2026

ADDRESS-LC: study protocol for a phase 2, triple-blind, randomised, placebo-controlled trial to evaluate the efficacy and safety of bezisterim (NE3107) in adults with long COVID.

ADDRESS-LC: study protocol for a phase 2, triple-blind, randomised, placebo-controlled trial to evaluate the efficacy and safety of bezisterim (NE3107) in adults with long COVID.

Journal: BMJ open

Published: July 24, 2026

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 02, 2026

Towards a long COVID prevention agenda.

Towards a long COVID prevention agenda.

Journal: The Lancet. Infectious diseases

Published: June 15, 2026

Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention control.

Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention control.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.

Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: May 11, 2026

Increased Mannosylation of Extracellular Vesicles in Long COVID Plasma as a Binding Target for Galanthus nivalis Agglutinin (GNA) Affinity Resin.

Increased Mannosylation of Extracellular Vesicles in Long COVID Plasma as a Binding Target for Galanthus nivalis Agglutinin (GNA) Affinity Resin.

Journal: International journal of molecular sciences

Published: May 06, 2026

Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.

Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.

Journal: Science translational medicine

Published: April 22, 2026

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy.

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy.

Journal: Nature immunology

Published: April 21, 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: April 05, 2026

Early immune responses anticipate HIV rebound and precede viral control.

Early immune responses anticipate HIV rebound and precede viral control.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Showing 1-12 of 244

Last Updated: 09/26/2026